Citation Impact
Citing Papers
Mediterranean Diet, Traditional Risk Factors, and the Rate of Cardiovascular Complications After Myocardial Infarction
1999 Standout
Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data
1997 Standout
Identification of the Interaction Site within Acyl-CoA:Cholesterol Acyltransferase 2 for the Isoform-specific Inhibitor Pyripyropene A
2008 StandoutNobel
Does the Early Administration of Beta‐blockers Improve the In‐hospital Mortality Rate of Patients Admitted with Acute Coronary Syndrome?
2010
Lipoprotein and cholesterol metabolism in diet-induced coronary artery atherosclerosis in primates.
1998
Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine
1995 Standout
Effect of Atenolol on Mortality and Cardiovascular Morbidity after Noncardiac Surgery
1996 Standout
Postinfarction Use of β-Blockers in Elderly Patients
1997
Medication Errors and Adverse Drug Events in Pediatric Inpatients
2001 Standout
Pharmacist Participation on Physician Rounds and Adverse Drug Events in the Intensive Care Unit
1999 Standout
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis
2006 Standout
The metabolic syndrome
2010 Standout
Role of Computerized Physician Order Entry Systems in Facilitating Medication Errors
2005 Standout
Exercise Standards for Testing and Training
2013 Standout
Associations of low density lipoprotein particle composition with atherogenicity
2004
Early intravenous beta-blockers in patients with acute coronary syndrome—A meta-analysis of randomized trials
2012
Infection Control — A Problem for Patient Safety
2003 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Health inequalities among British civil servants: the Whitehall II study
1991 Standout
Coronary heart disease: seven dietary factors
1991 Standout
Improving Safety with Information Technology
2003 Standout
Antioxidants and Atherosclerotic Heart Disease
1997 Standout
Cardiovascular Effects of n-3 Fatty Acids
1988 Standout
Abnormal membrane concentrations of 20 and 22-carbon essential fatty acids: A common link between risk factors and coronary and peripheral vascular disease?
1995
The metabolic syndrome
2005 Standout
Coronary heart disease in South Asians overseas: A review
1989
Hepatic origin of cholesteryl oleate in coronary artery atherosclerosis in African green monkeys. Enrichment by dietary monounsaturated fat.
1997
Scottish hearts but British habits.
1989
Potential role of potassium as a determinant of morbidity and mortality in patients with systemic hypertension and congestive heart failure
1990
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
2002 Standout
Cardiorespiratory Fitness as a Quantitative Predictor of All-Cause Mortality and Cardiovascular Events in Healthy Men and Women
2009 Standout
Quantifying heterogeneity in a meta‐analysis
2002 Standout
Low Plasma Vitamins E and C Increased Risk of Angina in Scottish Mena
1989
Effects of a Combination of Beta Carotene and Vitamin A on Lung Cancer and Cardiovascular Disease
1996 Standout
Bias in meta-analysis detected by a simple, graphical test
1997 Standout
Prevalence of the Metabolic Syndrome across Cardiorespiratory Fitness Levels in Women
2004
Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration
1994 Standout
A Computer-Assisted Management Program for Antibiotics and Other Antiinfective Agents
1998 Standout
Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials
2003 Standout
Effect of Intravenous Streptokinase on Left Ventricular Function and Early Survival after Acute Myocardial Infarction
1987
Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1
1987
Cardiac autonomic neural remodeling and susceptibility to sudden cardiac death: effect of endurance exercise training
2009
Aerobic exercise conditioning: a nonpharmacological antiarrhythmic intervention
2002
Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications.
1990 Standout
DIET AND RISK FACTORS FOR CORONARY HEART DISEASE IN ASIANS IN NORTHWEST LONDON
1985
Importance of Assessing Cardiorespiratory Fitness in Clinical Practice: A Case for Fitness as a Clinical Vital Sign: A Scientific Statement From the American Heart Association
2016 Standout
Evaluating the federal role in financing health-related research
1996 StandoutNobel
INFANT MORTALITY, CHILDHOOD NUTRITION, AND ISCHAEMIC HEART DISEASE IN ENGLAND AND WALES
1986 Standout
Systematic review and modelling of the investigation of acute and chronic chest pain presenting in primary care
2004
Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ
1997 Standout
ACAT2 Is Localized to Hepatocytes and Is the Major Cholesterol-Esterifying Enzyme in Human Liver
2004 StandoutNobel
Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
2008 Standout
LINOLEIC AND EICOSAPENTAENOIC ACIDS IN ADIPOSE TISSUE AND PLATELETS AND RISK OF CORONARY HEART DISEASE
1987
Hormone-electrolyte interactions in the pathogenesis of lethal cardiac arrhythmias in patients with congestive heart failure: Basis of a new physiologic approach to control of arrhythmia
1986
Blood pressure, stroke, and coronary heart disease
1990 Standout
Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data
2000 Standout
Beta blockade during and after myocardial infarction: An overview of the randomized trials
1985 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Global Burden of Cardiovascular Diseases
2001 Standout
Coronary Plaque Disruption
1995 Standout
Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
2000 Standout
Exercise and Physical Activity in the Prevention and Treatment of Atherosclerotic Cardiovascular Disease
2003 Standout
Treatment with Histamine H2Antagonists in Acute Upper Gastrointestinal Hemorrhage
1985 Standout
β2-Adrenergic Receptor Antagonists Protect Against Ventricular Fibrillation
1997
Physical training and insulin sensitivity
1986
Inhibition of Adenylyl Cyclase by G iα
1993 StandoutScienceNobel
Declining incidence of ventricular fibrillation in myocardial infarction. Implications for the prophylactic use of lidocaine.
1992
Social class and coronary heart disease.
1981
Part 14: Pediatric Advanced Life Support
2010 Standout
Conducting Meta-Analyses inRwith themetaforPackage
2010 Standout
Expert consensus document on ?-adrenergic receptor blockersThe Task Force on Beta-Blockers of the European Society of Cardiology
2004
Vitamin E Supplementation and Cardiovascular Events in High-Risk Patients
2000 Standout
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
2002 Standout
Linoleic acid content in adipose tissue and coronary heart disease.
1986
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
2002 Standout
Works of Robert L. Logan being referenced
Uncertainty in clinical practice: implications for quality and costs of health care
1996
PREVENTION OF VENTRICULAR FIBRILLATION DURING ACUTE MYOCARDIAL INFARCTION BY INTRAVENOUS PROPRANOLOL
1984
Symptoms associated with myocardial infarction: are they of diagnostic value?
1986
Histocompatibility Antigens and Myocardial Infarction
1977
RISK FACTORS FOR ISCHqMIC HEART-DISEASE IN NORMAL MEN AGED 40 Edinburgh?Stockholm Study
1978